Release date: 13 December 2021
Promoter – Financial Intermediary
GAVI ALLIANCELocation
Description
The project consists of a guarantee facility to support Gavi, the Vaccine Alliance investments in vaccines and in the immunisation supply chain.
Objectives
Guarantee facilities to support the activities of Gavi, the Vaccine Alliance. Gavi's objectives include accelerating access to new and underused vaccines with a particular focus on the lowest income countries, strengthening health and immunisation systems in partner countries and shaping the global vaccine market to the benefit of developing countries. The EIB's support, envisaged under the Cotonou Investment Facility, would increase long term funding predictability and decrease financing costs. By supporting further investment into the entire vaccine value chain, from manufacturers' research and development (R&D) to local supply chains and health systems in the African, Caribbean and Pacific (ACP) countries, the operation represents an opportunity to accelerate economic development and growth and to move countries closer to achieving their national objectives of poverty reduction. Immunisation is one of the most effective investments in global health and has a crucial role in achieving 14 of the 17 United Nations Sustainable Development Goals (SDGs). As one of the most far-reaching health interventions, it closely reflects the ethos of the SDGs: "leaving no one behind."
Sector(s)
- Health - Human health and social work activities
Proposed EIB finance (Approximate amount)
USD 226 million (EUR 203 million)
Total cost (Approximate amount)
USD 3300 million (EUR 2963 million)
Environmental aspects
If located in the EU, the project would not require an environmental impact assessment as per Directive 2014/52/EU amending the Environmental Impact Assessment (EIA) Directive 2011/92/EU, however environmental assessments might be required according to national law.
Procurement
The Bank will require the Promoter to ensure that implementation of the project will be done in accordance with the Bank's Guide to Procurement.
Status
Signed - 30/11/2021
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).